loadpatents
Patent applications and USPTO patent grants for Kennis; Ludo Edmond Josephine.The latest application filed is for "quinazolinone derivatives as parp inhibitors".
Patent | Date |
---|---|
Quinazolinone derivatives as PARP inhibitors Grant 10,150,757 - Guillemont , et al. Dec | 2018-12-11 |
Piperidin-4YL-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists Grant 9,751,860 - De Bruyn , et al. September 5, 2 | 2017-09-05 |
Quinazolinone Derivatives As Parp Inhibitors App 20170158673 - Guillemont; Jerome Emile ;   et al. | 2017-06-08 |
Fast Dissociating Dopamine 2 Receptor Antagonists App 20170022181 - De Bruyn; Marcel Frans Leopold ;   et al. | 2017-01-26 |
Quinazolinone derivatives as PARP inhibitors Grant 9,522,905 - Guillemont , et al. December 20, 2 | 2016-12-20 |
Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists Grant 9,468,640 - De Bruyn , et al. October 18, 2 | 2016-10-18 |
Quinazolinedione Derivatives As Parp Inhibitors App 20160108020 - Kennis; Ludo Edmond Josephine ;   et al. | 2016-04-21 |
Quinazolinedione derivatives as PARP inhibitors Grant 9,255,080 - Kennis , et al. February 9, 2 | 2016-02-09 |
Piperidin-4-yl-pyridazin-3-ylamine Derivatives As Fast Dissociating Dopamine 2 Receptor Antagonists App 20150141432 - De Bruyn; Marcel Frans, Leopold ;   et al. | 2015-05-21 |
Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists Grant 8,940,743 - De Bruyn , et al. January 27, 2 | 2015-01-27 |
Quinazolinedione Derivatives As Parp Inhibitors App 20140100239 - Kennis; Ludo Edmond Josephine ;   et al. | 2014-04-10 |
Quinazolinone Derivatives As Parp Inhibitors App 20140080835 - Guillemont; Jerome Emile Jorges ;   et al. | 2014-03-20 |
Quinazolinedione derivatives as PARP inhibitors Grant 8,623,884 - Kennis , et al. January 7, 2 | 2014-01-07 |
Quinazolinone derivatives as PARP inhibitors Grant 8,623,872 - Guillemont , et al. January 7, 2 | 2014-01-07 |
Quinazolinedione Derivatives As Parp Inhibitors App 20120065216 - Kennis; Ludo Edmond Josephine ;   et al. | 2012-03-15 |
Quinazolinedione derivatives as PARP inhibitors Grant 8,080,557 - Kennis , et al. December 20, 2 | 2011-12-20 |
2,4-disubstituted thiazolyl derivatives Grant 7,893,280 - Love , et al. February 22, 2 | 2011-02-22 |
Phthalazine derivatives as parp inhibitors Grant 7,803,795 - Mevellec , et al. September 28, 2 | 2010-09-28 |
Piperidin-4-Yl-Pyridazin-3-Ylamine Derivatives as Fast Dissociating Dopamine 2 Receptor Antagonists App 20080227791 - De Bruyn; Marcel Frans Leopold ;   et al. | 2008-09-18 |
Phthalazine Derivatives as Parp Inhibitors App 20080139568 - Mevellec; Laurence Anne ;   et al. | 2008-06-12 |
Quinazoline Derivatives as Parp Inhibitors App 20080070915 - Guillemont; Jerome Emile Georges ;   et al. | 2008-03-20 |
Quinazolinedione Derivatives as Parp Inhibitors App 20080039480 - Kennis; Ludo Edmond Josephine ;   et al. | 2008-02-14 |
Benzisoxazoles App 20070197610 - Kennis; Ludo Edmond Josephine ;   et al. | 2007-08-23 |
2,4-Disubstituted thiazolyl derivatives App 20060211704 - Love; Christopher ;   et al. | 2006-09-21 |
2,4-disubstituted thiazolyl derivatives Grant 7,105,550 - Love , et al. September 12, 2 | 2006-09-12 |
Benzothieno[3,2-c]pyridines as .alpha.2 antagonists Grant 6,774,129 - Kennis , et al. August 10, 2 | 2004-08-10 |
2,4-Disubstituted thiazolyl derivatives App 20030203897 - Love, Christopher ;   et al. | 2003-10-30 |
Tricyclic .DELTA.-3-piperidines as .alpha.2-antagonists Grant 6,495,555 - Kennis , et al. December 17, 2 | 2002-12-17 |
Tetrahydro gamma-carbolines App 20020103209 - Kennis, Ludo Edmond Josephine ;   et al. | 2002-08-01 |
Tricylic delta 3-piperidines as pharmaceuticals Grant 6,352,999 - Kennis , et al. March 5, 2 | 2002-03-05 |
Alkylaminobenzothiazole and-benzoxazole derivatives Grant 6,224,849 - Kennis , et al. May 1, 2 | 2001-05-01 |
1,2,3,4-tetrahydro-benzofuro[3,2-C]pyridine derivatives Grant 6,156,757 - Kennis , et al. December 5, 2 | 2000-12-05 |
Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs Grant 6,057,325 - Kennis , et al. May 2, 2 | 2000-05-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.